Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
C-MER Medical Holdings's quarterly market cap
declined
from Dec. 2024 (HK$2,500 Mil) to Jun. 2025 (HK$2,125 Mil) and
declined
from Jun. 2025 (HK$2,125 Mil) to Dec. 2025 (HK$2,047 Mil).
C-MER Medical Holdings's annual market cap
declined
from Dec. 2023 (HK$4,319 Mil) to Dec. 2024 (HK$2,500 Mil) and
declined
from Dec. 2024 (HK$2,500 Mil) to Dec. 2025 (HK$2,047 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. C-MER Medical Holdings's Enterprise Value for Today is HK$1,143 Mil.
C-MER Medical Holdings (HKSE:03309) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:03309 vs HCA, THC, DVA: Market Cap Comparison
For the Medical Care Facilities subindustry, C-MER Medical Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
C-MER Medical Holdings Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, C-MER Medical Holdings's Market Cap distribution charts can be found below:
* The bar in red indicates where C-MER Medical Holdings's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
C-MER Medical Holdings's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
C-MER Medical Holdings (HKSE:03309) has a Market Cap of HK$1,014 Mil as of Aug. 29, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on C-MER Medical Holdings and its competitors. According to the industry distribution chart, C-MER Medical Holdings ranks #329 out of 694 companies in the Healthcare Providers & Services industry, placing it in the top 47.4%.
Is C-MER Medical Holdings' Market Cap too high?
C-MER Medical Holdings' current Market Cap is HK$1,014 Mil. Based on the distribution chart, C-MER Medical Holdings ranks #329 out of 694 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, C-MER Medical Holdings has a GF Score™ of 83/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does C-MER Medical Holdings' Market Cap compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, C-MER Medical Holdings ranks #329 out of 694 companies for Market Cap. This puts C-MER Medical Holdings in the upper half of its industry. The industry median Market Cap is 111.28. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 111.28, based on 694 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on C-MER Medical Holdings and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 111.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. C-MER Medical Holdings's current Market Cap is HK$1,014 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is C-MER Medical Holdings stock overvalued right now?
Based on GuruFocus' analysis, C-MER Medical Holdings (HKSE:03309) is currently considered Possible Value Trap. The stock's GF Value™ is HK$2.77, compared to a current price of HK$0.86 — trading 69.1% below its estimated fair value. The current Market Cap is HK$1,014 Mil. C-MER Medical Holdings' overall GF Score™ is 83/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For C-MER Medical Holdings (HKSE:03309), the current Market Cap is HK$1,014 Mil as of Aug. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is C-MER Medical Holdings (HKSE:03309) Overvalued in 2026?
Based on GuruFocus' analysis, C-MER Medical Holdings stock appears to be undervalued.
The current stock price of HK$0.86 is trading 69.1% below its estimated GF Value™ of HK$2.77.
GuruFocus considers C-MER Medical Holdings to be Possible Value Trap.
Key valuation signals for HKSE:03309:
Market Cap: HK$1,014 Mil
GF Value™: HK$2.77 vs. price of HK$0.86 (69.1% below fair value)
No single metric tells the full story. See the HKSE:03309 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
C-MER Medical Holdings Ltd is a ophthalmic medical chain group in Hong Kong and the Greater Bay Area. With ophthalmology as its core, it has gradually expanded its business scope to different specialist services. The company through its subsidiaries are principally engaged in the provision of ophthalmic, dental and other medical services, sales of vision aid products and sales of medical consumables in Hong Kong and Mainland China. Geographically, the company generates revenue from Mailand China, and Hong Kong, with the majority of revenue generated from Mainland China.
83GF Score
Get the complete analysis for HKSE:03309
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:03309 has been successfully added to your 
